You might also like
DENTSPLY SIRONA Inc. (XRAY) is the world's largest manufacturer of professional dental products and technologies, with a 137-year history of innovation and service to the dental industry. The company is committed to improving oral health and continence care globally by developing, manufacturing, and marketing comprehensive solutions. These include technologically advanced dental equipment supported by cloud software solutions, as well as dental products and healthcare consumable products in urology and enterology under a strong portfolio of world-class brands.
- Essential Dental Solutions - Develops, manufactures, and sells value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices.
- Orthodontic and Implant Solutions - Designs, manufactures, and sells digital implant systems, innovative dental implant products, digital dentures, and dental professional-directed aligner solutions.
- Connected Technology Solutions - Designs, manufactures, and sells dental technology and equipment products, such as imaging systems, CAD/CAM systems, and treatment centers, supporting digital workflows for dental procedures.
- Wellspect Healthcare - Designs, manufactures, and sells innovative continence care solutions for urinary and bowel management, primarily consisting of urology catheters and other healthcare-related consumable products.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
Simon D. Campion ExecutiveBoard | President and Chief Executive Officer | None | Simon D. Campion has been the President and CEO of Dentsply Sirona since September 12, 2022. He previously served as Executive Vice President and President of the Medical Segment at Becton, Dickinson and Company (BD). | View Report → |
Andrea L. Frohning Executive | Senior Vice President and Chief Human Resources Officer | None | Andrea L. Frohning joined Dentsply Sirona in July 2023 as the Senior Vice President and CHRO. She has held senior HR leadership roles at Premier Incorporated, Patterson Dental, Snyder’s-Lance, and Crane Co.. | |
Richard C. Rosenzweig Executive | Executive Vice President, Corporate Development, General Counsel, and Secretary | Director’s Leadership Council at Rutgers Biomedical and Health Sciences; Rutgers Cancer Institute of New Jersey Director’s Leadership Council | Richard C. Rosenzweig joined Dentsply Sirona in February 2023. He has held senior legal roles at AngioDynamics and C. R. Bard Inc., and has extensive experience in corporate development and compliance. | |
Robert (Tony) A. Johnson Executive | Senior Vice President, Chief Supply Chain Officer | None | Robert (Tony) A. Johnson joined Dentsply Sirona in November 2022. He was previously President of Global Products and Supply Chain at Cardinal Health and held leadership roles at Becton Dickinson and Baxter International. | |
Betsy D. Holden Board | Director | Board Member at The Western Union Company, NNN REIT, Inc., and Kenvue Inc.; Member of the Food Chain Advisory Board and Paine Schwartz Partners | Betsy D. Holden has been a Director at Dentsply Sirona since 2018. She was formerly Co-CEO of Kraft Foods and has extensive experience in corporate governance and human resources. | |
Brian T. Gladden Board | Director | Chair of the Myasthenia Gravis Foundation; Advisory Council Member at Millersville University and University of Texas – Austin | Brian T. Gladden joined the Board of Dentsply Sirona on January 1, 2024. He has held CFO roles at Zelis Healthcare, Mondelēz International, and Dell Technologies, and was an Operating Partner with Bain Capital. | |
Clyde R. Hosein Board | Director | Board Member at Wolfspeed, Inc. and Credo Technology Group | Clyde R. Hosein has been a Director at Dentsply Sirona since 2020. He has held CFO roles at AliveCor, Automation Anywhere, RingCentral, and Marvell Technology Group, and has extensive experience in IT and financial management. | |
Daniel Scavilla Board | Director | Board Member at Globus Medical, Inc. | Daniel Scavilla joined the Board of Dentsply Sirona on February 5, 2025. He is the President and CEO of Globus Medical and has extensive experience in healthcare and finance. | |
Gregory T. Lucier Board | Non-Executive Chairman of the Board of Directors | CEO of Corza Health; Board Member at Catalent, Inc., Maravai LifeSciences Holdings, Inc., and Berkeley Lights, Inc. | Gregory T. Lucier has been a Director at Dentsply Sirona since 2019 and became Non-Executive Chairman on January 1, 2024. He has extensive leadership experience in healthcare and life sciences, including roles as Chairman and CEO of NuVasive and Life Technologies. | |
Janet S. Vergis Board | Director | Board Member at Church & Dwight Co., Inc., Teva Pharmaceutical Industries Ltd., and SGS SA; Chair of The Biotechnology Advisory Board | Janet S. Vergis has been a Director at Dentsply Sirona since 2019. She has over 35 years of experience in the healthcare industry, including roles as CEO of OraPharma and President of Janssen Pharmaceuticals at Johnson & Johnson. | |
Michael Barber Board | Director | Board Member at Exact Sciences, Inc.; Executive Committee Member at Green Bay Packers Football Club; Board of Regents at Milwaukee School of Engineering | Michael Barber joined the Board of Dentsply Sirona on February 5, 2025. He has over 40 years of experience in executive roles at General Electric, focusing on diagnostic imaging and point-of-care technology. | |
Willie A. Deese Board | Director | Chair of the Corporate Governance Committee at Public Service Enterprise Group, Inc. | Willie A. Deese has been a Director at Dentsply Sirona since 2011. He retired from Merck & Co., Inc. in 2016 after serving as Executive Vice President and President of the Merck Manufacturing Division. |
-
Given the sustained macroeconomic pressures and the $500 million goodwill impairment in the Orthodontic and Implant Solutions segment, what specific steps are you taking to turn around performance in this segment, particularly in the underperforming implants business?
-
With the voluntary suspension of Byte operations and the potential discontinuation of this business, how do you plan to mitigate the impact on your top-line revenue and bottom-line profitability, and what are the long-term implications for your clear aligner strategy?
-
Despite achieving $200 million in annualized savings from the first restructuring program and initiating a second phase targeting $80 million to $100 million in savings, earnings have remained flat year-over-year; can you explain why these cost savings have not translated into improved profitability, and how you plan to address this issue moving forward?
-
Given the challenges in the U.S. equipment market and the continued pressure on elective procedures, how realistic is your goal to achieve growth in these areas, and what specific initiatives are in place to drive demand in a weak macro environment?
-
Your SKU optimization efforts aim to eliminate non-revenue-generating SKUs by the end of this year and migrate most revenue-generating SKUs in 2025; can you provide more details on how this will positively impact financial performance and when we can expect to see these benefits reflected in your results?
| Customer | Relationship | Segment | Details |
|---|---|---|---|
Henry Schein, Inc. | Major global dental distributor | All | 14% of net sales (2023) ; 11% of A/R (2023) ; 11% of net sales (2022) ; 15% of A/R (2022) ; no single concentration in 2024. |
Patterson Companies, Inc. | Major global dental distributor | All | 10% of A/R (2023) ; 12% of A/R (2022) ; no single concentration in 2024. |
Recent press releases and 8-K filings for XRAY.
- Bridge Loan Agreement executed on March 19, 2025 for a $435 million term loan with a maturity date of March 18, 2026, aimed at repaying commercial paper and funding general corporate purposes.
- Goldman Sachs Bank USA is designated as Administrative Agent, Sole Bookrunner, and Sole Lead Arranger, with the facility featuring interest rate options based on forward-looking benchmarks and scheduled duration fees .
- Aligner and CTS Business Growth: Management highlighted strong performance in the aligner segment with over 20% growth in Europe and noted a significant turnaround in Germany, where a reintroduced mid-range CBCT helped achieve the best quarter in several periods.
- Expansion of Digital Ecosystem: The company is advancing its digital strategy with the integration of DS Core and Primescan 2, including forthcoming software updates to improve upload/download speeds and overall functionality, reinforcing its position in connected dentistry.
- Investments in Inside Sales and Market Intelligence: A robust inside sales force has been deployed—now contacting 16,000 accounts—to drive incremental revenue, gather market intelligence, and free up field reps to target larger accounts.
- Operational Efficiency and Cost Reduction Initiatives: Ongoing back-office streamlining, including significant cost cuts and sales rep retraining, are central to the company’s strategy to bolster clinical offerings and support sustainable growth.